Immunotherapy methods emerged on the oncology market as adoptive cell transfers, specifically chimeric antigen receptor (CAR) T-cell therapies, with clear benefits in hematologic malignancy treatment.
Heather N. Wolf
Advertisement
Articles by Heather N. Wolf
Advertisement
Latest Updated Articles
Combating Advancing Cancers With CAR T-Cell TherapyPublished: September 8th 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA, HHS Move to Accelerate Biosimilar Approvals
2
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
3
Accelerated Approval of Cancer Drugs: Benefit or Burden?
4
Pharmacists Lead the Way in Evolving CAR T-Cell and Bispecific Antibody Therapy Management
5
